Re-Vana Therapeutics | Oculief® formulation

Our client Lent Innovations aims to set a new standard for pediatric anaphylaxis treatment by developing an epinephrine injector tailored to the specific needs of children, to reduce the risk of use errors and incorrect injection technique. The goal is to ensure that delivery of life-saving medication is e...

Cambridge Design Partnership is delighted to be co-developing KORU Medical Systems’ next-generation subcutaneous infusion device.

KORU Medical Systems is a leader in large volume subcutaneous infusion devices, with 40,000 patients performing 1.5 million infusions globally every year.

Thi...

Cambridge Design Partnerships are collaborating with Lent Innovations to develop a novel Epinephrine injector device, specifically designed to address critical usability challenges.

Current devices often present issues such as incorrect handling, device slippage during activation, high activation...

What if unpacking medication could be as engaging as unboxing a new iPhone? Could design cues reassure the patient of drug integrity? Step-by-step opening signal ease of use, or empathetic design reduce patient anxiety? 

This session will explore the value of considering the user experience for patients and how best to build it. What does the consumer sector have to show drug delivery about creating compelling experiences and reassuring users? How can packaging guide users during their journey, from onboarding to successful regimen adherence? And what does it take to unify physical and digital components and convince users of connectivity’s benefits? This session was broadcast as part of the Pharmapack show.

Innovation in the design and development of large volume drug delivery devices can solve the challenge of accommodating the increasing trend towards patient self-administration and home care while at the same time ensuring that drugs that require intravenous administration are delivered correctly and safely.

Many of the drugs in development pipelines today are biologics, which despite their therapeutic advantages can pose drug delivery and administration challenges. For Pharma companies developing delivery solutions for biologics, the patient experience is always central to the success of a device. As many biologics need to be administered intravenously by a healthcare professional, this conflicts with the increasing trend towards self-administration and home care. To tackle this challenge, there are now several solutions on the market designed specifically for large volume drugs – from auto-injectors to wearables and smart devices. This webinar will provide an overview of the large volume drug delivery challenge, and the most innovative solutions on the market today for improving patient adherence and experience. Key Discussion Points The large volume drug delivery challenge and market growth outlook Optimizing the patient experience through customizable solutions Innovative solutions on the market Partner selection for large volume drug delivery devices Why attend? Get the complete overview on the large volume drug delivery device for 2021 in just 60 minutes Hear from experts who share their learned lessons for commercialized device solution, market impacts and successful device development strategies